Dr. Royston Clowes, a renowned researcher and bacterial geneticist who is also regarded as a founding faculty leader of the Graduate Research Center of the Southwest (now The University of Texas, Dallas) will be honored for his achievements and contributions at a public lecture on April 3, 2013 in the TI Auditorium at UT Dallas.
Dr. Royston Clowes joined the Graduate Research Center of the Southwest in 1965 and led the development of the GRCS for the University of Texas 4 years later. He served as head of the Biology Division for 6 years (1968- 1974), and after a break of 5 years, joined again in 1979 until his death in 1989.
Clowes contributed a great deal to the field of molecular genetics and biotechnology. His notable work includes contributions in better understanding of plasmid biology that forms the basis of recombinant DNA technology, the development of drug kinetics, laboratory research, drug resistance, and biotechnology.
The Royston Clowes Memorial Lecture Series was initiated in 1900 by a UT Dallas organization –“The Biology Graduate Student Organization” — to honor the contributions, developments and services of Clowes to the university and to the world of medicine. The Clowes Memorial Endowment partially funded the lecture series.
The 23rd Royston Clowes Memorial Lecture to be Given by Dr. Michael White:
The lecture will be given at UT Southwestern Medical Center, on the topic “Harnessing Cancer Genome Diversity for Intervention Target Identification and Development” in TI Auditorium in the Engineering and Computer Science Building (ECSS 2.102) on April 3rd, 2013 at 5 PM. Another lecture will be conducted for researchers and students earlier in the day (at 10:45 AM) at TI auditorium with the title “Coordination of Cellular Growth and Self-renewal Programs by Ras-like GTPases and the Exocyst”
The speaker, Dr. Michael White, is a professor of Cell Biology, and he will discuss the challenges faced by clinicians in identifying the appropriate and personalized treatment for patients. Personalized medicine is designed according to the genetic and metabolic needs of the patient and is therefore far more effective than traditional customized therapies.
The organizers commented on choosing Dr. White as the speaker in these words:
“We chose Dr. White as our speaker because faculty, students and staff from various backgrounds are interested in cancer research and medicine. We hope that his work will inspire our students who are seeking lab experience or a future career in research.”
Dr. Michael White has the honor of holding the Sherry Wigley Crow Cancer Research Endowed Chair to pay tribute to Robert Lewis Kirby, M.D and Grant A. Dove Chair for Research. White’s notable contribution in the field of molecular biology focuses on the molecular factors that may affect cellular growth and differentiation. The research not only helped in learning the basic cell biology but also led to the development of cancer biology and drug kinetics and mechanics.